Cargando...
Sustainable therapies by engineered bacteria
The controlled in situ delivery of biologics (e.g. enzymes, cytokines, antibodies) by engineered bacteria of our microbiome will allow the sustainable production of these complex and expensive drugs locally in the human body, overcoming many of the technical and economical barriers currently associa...
Gardado en:
| Publicado en: | Microb Biotechnol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609241/ https://ncbi.nlm.nih.gov/pubmed/28696008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1751-7915.12778 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|